Back to search
FDAFDA · Food and drugs·Recall number D-0446-2024

S.P.Labs, Thyroid, Full Strength, Rx only, For Manufacturing, Processing or Repackaging Use Only, Specialty Process Labs, Phoenix, AZ 85034, NDC 81305-500-01.

Published April 24, 2024 · Recall initiated: March 1, 2024

Summary

FDA records drug Class II recall D-0446-2024, published April 24, 2024 and initiated March 1, 2024. Recalling firm: Specialty Process Labs LLC; Status: Completed; Reported quantity: 26 units; Lot: Lot #: H22212-FSV, Exp: 11/21/2024 1.0 kg pack size. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Stability Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Specialty Process Labs LLC
Distributor
U.S. Nationwide.
Lot
Lot #: H22212-FSV, Exp: 11/21/2024 1.0 kg pack size.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was S.P.Labs, Thyroid, Full Strength, Rx only, For Manufacturing, Processing or Repackaging Use Only, Specialty Process Labs, Phoenix, AZ 85034, NDC 81305-500-01. recalled?

Yes. FDA published recall D-0446-2024 on April 24, 2024. Reported hazard: Failed Stability Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter